CNS & Tick-Borne Panel Genetic Testing is an advanced molecular diagnostic tool that uses genetic technologies like PCR or Next-Generation Sequencing (NGS) to detect DNA or RNA from pathogens affecting the central nervous system (CNS) and those transmitted by ticks. This test identifies a wide range of viral, bacterial, fungal, and parasitic organisms that may cause serious conditions such as meningitis, encephalitis, Lyme disease, and other neuroinvasive infections. By analyzing cerebrospinal fluid (CSF) or blood samples, this testing offers rapid, accurate results, aiding in early diagnosis, targeted treatment, and better management of complex neurological or tick-borne illnesses.
This testing is crucial for the timely and accurate diagnosis of serious and potentially life-threatening infections that affect the brain and nervous system or result from tick bites. Traditional methods often take days and may miss certain pathogens, but genetic testing offers rapid, precise detection of multiple organisms in a single test. It helps avoid unnecessary treatments, reduces hospital stays, and guides physicians toward the most effective therapy. Especially in cases with vague or overlapping neurological symptoms, this comprehensive panel ensures no critical pathogen is overlooked, improving patient outcomes and enabling early, targeted intervention.
Individuals experiencing unexplained neurological symptoms, especially after tick exposure or in high-risk environments, should consider this testing. It is particularly important for those in areas where tick-borne diseases are endemic, and for patients whose symptoms progress rapidly or don’t respond to standard treatments. The test is also valuable for vulnerable groups, such as children, the elderly, or immunocompromised individuals, where early and accurate diagnosis is critical to prevent complications.
You should consider this test if:
A healthcare provider assesses symptoms like fever, headache, confusion, seizures, or history of tick exposure to determine the need for testing.
A cerebrospinal fluid (CSF) sample is collected via lumbar puncture (spinal tap). In some cases, a blood sample may also be taken.
The laboratory isolates genetic material (DNA or RNA) from the pathogens present in the sample.
Using Polymerase Chain Reaction (PCR) or Next-Generation Sequencing (NGS), the extracted genetic material is amplified to detect even trace levels of pathogens.
The amplified material is matched against a database of known CNS and tick-borne pathogens (bacteria, viruses, fungi, parasites).
A detailed report is generated, indicating which, if any, pathogens were detected, helping physicians make accurate and timely treatment decisions.
Our fully integrated E-Lab platform offers online test ordering, real-time tracking, and secure digital reporting bringing convenience and control to both physicians and patients across the country.
From routine blood tests to complex genetic panels, we leverage cutting-edge platforms like NGS, PCR, and AI-powered analytics for maximum accuracy and clinical relevance.
With lab facilities based in Florida, we ensure faster processing times and direct access to our expert team. You get timely results backed by responsive, local customer support.
At E-lab, we are dedicated to innovation, collaboration, and seamless growth.